Gene Expression Market Growth, Size, Trends , Analysis 2034
Global Gene Expression Market Growth, Size, Trends Analysis - By Product, By Technique, By Process, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jun-2025 | Report ID: HLCA25190 | Pages: 1 - 256 | Formats*: |
| Category : Healthcare | |||
Gene Expression Market Introduction and Overview
According to SPER Market Research, the Global Gene Expression Market is estimated to reach USD 25.9 billion by 2034 with a CAGR of 5.26%.
The report includes an in-depth analysis of the Global Gene Expression Market, including market size and trends, product mix, Applications, and supplier analysis. The global gene expression market was estimated at USD 15.51 billion in 2024 and is projected to increase at a compound annual growth rate (CAGR) of 5.26% between 2025 and 2034. Advances in genomics, rising desire for personalised treatment, and an increase in the frequency of chronic diseases such as cardiovascular disease, cancer, and neurological disorders are the primary drivers of the industry.
By Product Insights
The kits and reagents segment also captured a large revenue share in 2024, attributed to numerous companies providing a wide range of products for gene expression. For example, Agilent Technologies offers a variety of gene expression microarray kits. The growth in this segment is supported by the launch of advanced products aimed at specific applications. DNA chips, which are used in gene expression analysis, are expected to see the highest growth rate during the forecast period. These DNA microarrays, containing thousands of gene-specific spots, are important for detecting diseases and understanding therapeutic responses in biomedical research.
By Technique Insights
RNA expression also held a significant revenue share in 2024, with RNA-sequencing (RNA-seq) becoming a popular method in clinical research for comparing gene expression levels. In cancer studies, RNA-seq helps in understanding biological functions and discovering biomarkers. Promoter analysis, on the other hand, is anticipated to experience the fastest growth in the forecast period, crucial for understanding gene regulation and identifying factors influencing gene activity. This technique has applications in drug discovery, genetic disorders, and diagnostics.
By Process Insights
CDNA synthesis and conversion generated the most revenue in 2024, mainly due to a variety of kits designed to meet diverse research needs. The ongoing introduction of new cDNA synthesis and library preparation kits is expected to boost this segment further. Data analysis and interpretation are projected to grow the fastest during the forecast period, driven by significant investments in cancer research and an increase in demand for advanced software for cancer gene expression studies. New methods and algorithms are being developed to analyze gene expression in complex diseases such as cancer, including projective clustering and ensemble techniques.
By Application Insights
In the drug discovery and development sector, gene-expression profiling has become a vital tool, allowing pharmaceutical companies to assess drug effectiveness and toxicity by monitoring cellular gene activity. Conventional profiling techniques can be costly, often making them impractical. Clinical diagnostics is expected to grow rapidly from 2025 to 2034 due to increased use of gene analysis for diagnosing genetic disorders and understanding disease progression. This insight supports early detection and the identification of biomarkers essential for patient care.
Regional Insights
North America led the gene expression market in 2024, capturing the largest revenue share due to increased funding and research efforts, especially in the U. S. Factors like the growing significance of gene expression studies, government support, and funding for NGS research also contributed to this growth. Asia Pacific is expected to have the fastest growth rate due to rising R&D investments and a large population in countries like India and China, which enhances personalized healthcare. Japan plays a key role with its strong academic institutions and advanced biotech sector supporting market growth.
Market Competitive Landscape
The competitive environment of the gene expression industry is distinguished by the presence of established pharmaceutical corporations seeking for market share. Key players are strengthening their product portfolios through strategic activities such as mergers, acquisitions, and alliances. The companies are actively pursuing a multifaceted approach to meet the growing need for effective gene expression.
Recent Developments:
In January 2023, QIAGEN Digital Insights launched the QIAGEN CLC Genomics Workbench Premium. This tool aims to solve the data-analysis bottleneck in next-generation sequencing by speeding up the analysis and interpretation of whole exome sequencing, whole genome sequencing, and large panel sequencing data.
In May 2023, Thermo Fisher Scientific and Pfizer joined forces to increase localised access to Next-generation Sequencing-based testing for cancer patients in more than 30 countries throughout Latin America, Africa, the Middle East and Asia.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Technique, By Process, By Application |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | QIAGEN, Quest Diagnostics, Inc, F. Hoffmann-La Roche Ltd, Illumina, Inc, PerkinElmer, Inc, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc, Agilent Technologies, GE Healthcare, Danaher Corp. |
Key Topics Covered in the Report
- Global Gene Expression Market Size (FY’2021-FY’2034)
- Overview of Global Gene Expression Market
- Segmentation of Global Gene Expression Market By Product (Kits & Reagents, DNA Chips, Others)
- Segmentation of Global Gene Expression Market By Technique (RNA Expression, Promoter Analysis, Protein Expression & Posttranslational Modification Analysis)
- Segmentation of Global Gene Expression Market By Process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation)
- Segmentation of Global Gene Expression Market By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others)
- Statistical Snap of Global Gene Expression Market
- Expansion Analysis of Global Gene Expression Market
- Problems and Obstacles in Global Gene Expression Market
- Competitive Landscape in the Global Gene Expression Market
- Details on Current Investment in Global Gene Expression Market
- Competitive Analysis of Global Gene Expression Market
- Prominent Players in the Global Gene Expression Market
- SWOT Analysis of Global Gene Expression Market
- Global Gene Expression Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Gene Expression Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Gene Expression Market
7.Global Gene Expression Market, By Product (USD Million) 2021-2034
7.1.Kits & Reagents7.2.DNA Chips7.3.Others
8.Global Gene Expression Market, By Technique (USD Million) 2021-2034
8.1.RNA Expression8.2.Promoter Analysis8.3.Protein Expression & Posttranslational Modification Analysis
9.Global Gene Expression Market, By Process (USD Million) 2021-2034
9.1.Sample Collection9.2.Purification9.3.cDNA synthesis & conversion9.4.PCR Analysis9.5.Data analysis & interpretation
10.Global Gene Expression Market, By Application (USD Million) 2021-2034
10.1.Drug Discovery & Development10.2.Clinical Diagnostics10.3.Biotech & Microbiology10.4.Others
11.Global Gene Expression Market, (USD Million) 2021-2034
11.1.Global Gene Expression Market Size and Market Share
12.Global Gene Expression Market, By Region, (USD Million) 2021-2034
12.1.Asia-Pacific12.1.1.Australia12.1.2.China12.1.3.India12.1.4.Japan12.1.5.South Korea12.1.6.Rest of Asia-Pacific12.2.Europe12.2.1.France12.2.2.Germany12.2.3.Italy12.2.4.Spain12.2.5.United Kingdom12.2.6.Rest of Europe12.3.Middle East and Africa12.3.1.Kingdom of Saudi Arabia12.3.2.United Arab Emirates12.3.3.Qatar12.3.4.South Africa12.3.5.Egypt12.3.6.Morocco12.3.7.Nigeria12.3.8.Rest of Middle-East and Africa12.4.North America12.4.1.Canada12.4.2.Mexico12.4.3.United States12.5.Latin America12.5.1.Argentina12.5.2.Brazil12.5.3.Rest of Latin America
13.Company Profile
13.1.Catalent Inc13.1.1.Company details13.1.2.Financial outlook13.1.3.Product summary13.1.4.Recent developments13.2.QIAGEN13.2.1.Company details13.2.2.Financial outlook13.2.3.Product summary13.2.4.Recent developments13.3.Quest Diagnostics, Inc13.3.1.Company details13.3.2.Financial outlook13.3.3.Product summary13.3.4.Recent developments13.4.F. Hoffmann-La Roche Ltd13.4.1.Company details13.4.2.Financial outlook13.4.3.Product summary13.4.4.Recent developments13.5.Illumina, Inc13.5.1.Company details13.5.2.Financial outlook13.5.3.Product summary13.5.4.Recent developments13.6.PerkinElmer, Inc13.6.1.Company details13.6.2.Financial outlook13.6.3.Product summary13.6.4.Recent developments13.7.Bio-Rad Laboratories13.7.1.Company details13.7.2.Financial outlook13.7.3.Product summary13.7.4.Recent developments13.8.Thermo Fisher Scientific, Inc13.8.1.Company details13.8.2.Financial outlook13.8.3.Product summary13.8.4.Recent developments13.9.Agilent Technologies13.9.1.Company details13.9.2.Financial outlook13.9.3.Product summary13.9.4.Recent developments13.10.GE Healthcare13.10.1.Company details13.10.2.Financial outlook13.10.3.Product summary13.10.4.Recent developments13.11.Danaher Corp.13.11.1.Company details13.11.2.Financial outlook13.11.3.Product summary13.11.4.Recent developments13.12.Others
14.Conclusion
15.List of Abbreviations
16.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Gene Expression Market is projected to reach USD 25.9 by 2034, growing at a CAGR of 5.26% during the forecast period.
Gene Expression Market size from 2025. The Market is expected to reach USD 25.9 by 2034, at a CAGR of 5.26% during the forecast period.
Gene Expression Market CAGR of 5.26% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Gene Expression Market size is USD 25.9 from 2025 to 2034.
"Gene Expression Market covered By Product, By Technique, By Process, By Application
"
The North America is anticipated to have the highest Market share in the Gene Expression Market .
"
QIAGEN, Quest Diagnostics, Inc, F. Hoffmann-La Roche Ltd, Illumina, Inc, PerkinElmer, Inc, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc, Agilent Technologies, GE Healthcare, Danaher Corp."
The report includes an in-depth analysis of the Global Gene Expression Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
